{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T10:44:58Z","timestamp":1784717098838,"version":"3.55.0"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974131"],"award-info":[{"award-number":["81974131"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82471064"],"award-info":[{"award-number":["82471064"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012669","name":"Natural Science Foundation Project of Chongqing","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012669","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing Municipality","doi-asserted-by":"publisher","award":["CSTB2024NSCQ-KJFZMSX0073"],"award-info":[{"award-number":["CSTB2024NSCQ-KJFZMSX0073"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.ejphar.2025.178090","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T23:15:32Z","timestamp":1756250132000},"page":"178090","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Ocular safety evaluation of toplic and systemic antifungal medications: A multi-source pharmacovigilance and genomic study"],"prefix":"10.1016","volume":"1005","author":[{"given":"Dangdang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyu","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4585-0071","authenticated-orcid":false,"given":"Yufan","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqin","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujia","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaowen","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.178090_bib1","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1080\/09273948.2020.1781903","article-title":"Voriconazole induced ocular surface dysplasia - report of two cases","volume":"30","author":"Agarwal","year":"2022","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.ejphar.2025.178090_bib2","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/15569527.2018.1463237","article-title":"Topically applied 1% voriconazole induces dysplastic changes on the ocular surface: animal study","volume":"37","author":"Arikan","year":"2018","journal-title":"Cutan. Ocul. Toxicol."},{"key":"10.1016\/j.ejphar.2025.178090_bib3","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1177\/10781552221076756","article-title":"Papilledema and idiopathic intracranial hypertension due to the possible potentiation of ATRA by posaconazole in a case of acute promyelocytic leukemia","volume":"28","author":"Atas","year":"2022","journal-title":"J. Oncol. Pharm. Pract."},{"key":"10.1016\/j.ejphar.2025.178090_bib4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2147\/OPTH.S447138","article-title":"Fungal keratitis: diagnosis, management, and recent advances","volume":"18","author":"Awad","year":"2024","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.ejphar.2025.178090_bib5","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nature24277","article-title":"Genetic effects on gene expression across human tissues","volume":"550","author":"Battle","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2025.178090_bib6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2165\/00002018-199920020-00002","article-title":"The medical dictionary for regulatory activities (MedDRA)","volume":"20","author":"Brown","year":"1999","journal-title":"Drug Saf."},{"key":"10.1016\/j.ejphar.2025.178090_bib7","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet. Epidemiol."},{"key":"10.1016\/j.ejphar.2025.178090_bib8","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41419-022-04963-x","article-title":"The role of the PI3K\/AKT signalling pathway in the corneal epithelium: recent updates","volume":"13","author":"Chen","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2025.178090_bib9","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/bcpt.12530","article-title":"Variability of voriconazole trough levels in haematological patients: influence of comedications with cytochrome P450(CYP) inhibitors and\/or with CYP inhibitors plus CYP inducers","volume":"118","author":"Cojutti","year":"2016","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2025.178090_bib10","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.1128\/AAC.00423-11","article-title":"Pharmacokinetics of voriconazole administered concomitantly with fluconazole and population-based simulation for sequential use","volume":"55","author":"Damle","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejphar.2025.178090_bib11","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1128\/CMR.00113-16","article-title":"Bacterial and fungal endophthalmitis","volume":"30","author":"Durand","year":"2017","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejphar.2025.178090_bib12","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/pds.677","article-title":"Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports","volume":"10","author":"Evans","year":"2001","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.ejphar.2025.178090_bib13","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1001\/archopht.1981.03930011081019","article-title":"Ocular toxicity of topical antifungal agents","volume":"99","author":"Foster","year":"1981","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ejphar.2025.178090_bib14","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1128\/CMR.12.4.501","article-title":"Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance","volume":"12","author":"Ghannoum","year":"1999","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ejphar.2025.178090_bib15","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1177\/10600280221148031","article-title":"Drugs that interact with colchicine via inhibition of cytochrome P450 3A4 and P-Glycoprotein: a signal detection analysis using a database of spontaneously reported adverse events (FAERS)","volume":"57","author":"G\u00f3mez-Lumbreras","year":"2023","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ejphar.2025.178090_bib16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4103\/0301-4738.53051","article-title":"Review of epidemiological features, microbiological diagnosis and treatment outcome of microbial keratitis: experience of over a decade","volume":"57","author":"Gopinathan","year":"2009","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.ejphar.2025.178090_bib17","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.ophtha.2010.03.048","article-title":"Trends in fungal keratitis in the United States, 2001 to 2007","volume":"117","author":"Gower","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejphar.2025.178090_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1573353","article-title":"Exploring the complexities of disproportionality analysis in pharmacovigilance: reflections on the READUS-PV guideline and a call to action","volume":"16","author":"Hammad","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178090_bib19","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1021\/acs.molpharmaceut.0c01154","article-title":"Carboxylesterase activities and protein expression in rabbit and pig ocular tissues","volume":"18","author":"Hammid","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejphar.2025.178090_bib20","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.1128\/AAC.00569-11","article-title":"Cytotoxicity of voriconazole on cultured human corneal endothelial cells","volume":"55","author":"Han","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejphar.2025.178090_bib21","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1136\/bjophthalmol-2011-301129","article-title":"Toxicity of voriconazole on corneal endothelial cells in an animal model","volume":"96","author":"Han","year":"2012","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ejphar.2025.178090_bib22","article-title":"Conjunctiva necrosis following subconjunctival amphotericin B injection in fungal keratitis","volume":"11","author":"Han Shu","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.ejphar.2025.178090_bib23","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1080\/02713683.2022.2091147","article-title":"Toxicity of amphotericin B in rabbit corneal epithelial cells stored in Optisol\u2122-GS: corneal epithelial cell morphology and migration","volume":"47","author":"Harada","year":"2022","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.ejphar.2025.178090_bib24","article-title":"Fungal endophthalmitis: a comprehensive review","volume":"7","author":"Haseeb","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.ejphar.2025.178090_bib25","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ophtha.2021.12.004","article-title":"Topical chlorhexidine 0.2% versus topical natamycin 5% for the treatment of fungal keratitis in Nepal: a randomized controlled noninferiority trial","volume":"129","author":"Hoffman","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejphar.2025.178090_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1292163","article-title":"Clinical drug interactions between voriconazole and 38 other drugs: a retrospective analysis of adverse events","volume":"15","author":"Huo","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178090_bib27","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.icl.0000249595.27520.2e","article-title":"Fungal keratitis: emerging trends and treatment outcomes","volume":"32","author":"Iyer","year":"2006","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.ejphar.2025.178090_bib28","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1080\/08820538.2021.1966059","article-title":"Systemic immunosuppression in cornea and ocular surface disorders: a ready reckoner for ophthalmologists","volume":"37","author":"Kate","year":"2022","journal-title":"Semin. Ophthalmol."},{"key":"10.1016\/j.ejphar.2025.178090_bib29","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jclinepi.2021.01.015","article-title":"Adverse drug reaction risks obtained from meta-analyses and pharmacovigilance disproportionality analyses are correlated in Most cases","volume":"134","author":"Khouri","year":"2021","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.ejphar.2025.178090_bib30","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1089\/jop.2014.0044","article-title":"Toxicity of topical antifungal agents to stratified human cultivated corneal epithelial sheets","volume":"30","author":"Kimakura","year":"2014","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.ejphar.2025.178090_bib31","doi-asserted-by":"crossref","first-page":"5058","DOI":"10.1167\/iovs.11-7183","article-title":"Mechanism of voriconazole-induced transient visual disturbance: reversible dysfunction of retinal ON-bipolar cells in monkeys","volume":"52","author":"Kinoshita","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejphar.2025.178090_bib32","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2025.178090_bib33","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/bjo.73.5.397","article-title":"Amphotericin B induced ocular toxicity in cryptococcal meningitis","volume":"73","author":"Li","year":"1989","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ejphar.2025.178090_bib34","article-title":"Real-world pharmacovigilance analysis of drug-related conjunctivitis using the FDA adverse event reporting system database","volume":"15","author":"Li","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2025.178090_bib35","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s12640-017-9826-6","article-title":"Antibiotics reduce retinal cell survival in vitro","volume":"33","author":"Lindsey","year":"2018","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ejphar.2025.178090_bib36","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3109\/09273948.2010.507320","article-title":"Cystoid macular edema secondary to fluconazole toxicity","volume":"18","author":"Magrath","year":"2010","journal-title":"Ocul. Immunol. Inflamm."},{"key":"10.1016\/j.ejphar.2025.178090_bib37","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/APO.0b013e3182a618dd","article-title":"Effectiveness of topical antifungal drugs in the management of fungal keratitis: a systematic review and meta-analysis of randomized controlled trials","volume":"3","author":"McDonald","year":"2014","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"10.1016\/j.ejphar.2025.178090_bib38","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1038\/s41433-021-01768-8","article-title":"Evaluation of in vitro activity of five antimicrobial agents on acanthamoeba isolates and their toxicity on human corneal epithelium","volume":"36","author":"Megha","year":"2022","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.ejphar.2025.178090_bib39","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1080\/15569527.2023.2226714","article-title":"Toxicity of simultaneous intrastromal and intracameral injection of voriconazole on corneal endothelium in a rabbit model","volume":"42","author":"Moon","year":"2023","journal-title":"Cutan. Ocul. Toxicol."},{"key":"10.1016\/j.ejphar.2025.178090_bib40","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jtos.2021.10.007","article-title":"The vision-related burden of dry eye","volume":"23","author":"Morthen","year":"2022","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.ejphar.2025.178090_bib41","doi-asserted-by":"crossref","first-page":"Np11","DOI":"10.1177\/1120672117750051","article-title":"Macular toxicity and blind spot enlargement during a treatment by voriconazole: a case report","volume":"28","author":"Mounier","year":"2018","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.ejphar.2025.178090_bib42","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/ICU.0000000000000860","article-title":"Effects of systemic targeted immunosuppressive therapy on ocular surface","volume":"33","author":"Mukhtar","year":"2022","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.ejphar.2025.178090_bib43","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.ophtha.2019.03.020","article-title":"Mycotic antimicrobial localized injection: a randomized clinical trial evaluating intrastromal injection of voriconazole","volume":"126","author":"Narayana","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejphar.2025.178090_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40264-024-01473-x","article-title":"Caveats of covariate adjustment in disproportionality analysis for best practices","volume":"48","author":"Noguchi","year":"2025","journal-title":"Drug Saf."},{"key":"10.1016\/j.ejphar.2025.178090_bib45","first-page":"7823","article-title":"Toxic optic neuropathy due to voriconazole: possible potentiation by reduction of CYP2C19 activity","volume":"25","author":"Orssaud","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2025.178090_bib46","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1097\/ICO.0000000000000181","article-title":"Toxicity of intrastromal voriconazole injection on corneal endothelium in rabbits","volume":"33","author":"Park","year":"2014","journal-title":"Cornea"},{"key":"10.1016\/j.ejphar.2025.178090_bib47","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1001\/jamaophthalmol.2016.4096","article-title":"Effect of oral voriconazole on fungal keratitis in the mycotic ulcer treatment trial II (MUTT II): a randomized clinical trial","volume":"134","author":"Prajna","year":"2016","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.ejphar.2025.178090_bib48","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ophtha.2019.08.029","article-title":"Cross-linking-assisted infection reduction: a randomized clinical trial evaluating the effect of adjuvant cross-linking on outcomes in fungal keratitis","volume":"127","author":"Prajna","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejphar.2025.178090_bib49","doi-asserted-by":"crossref","first-page":"346","DOI":"10.4103\/ijo.IJO_1163_17","article-title":"Reply to comment on: fungal keratitis: the aravind experience","volume":"66","author":"Prajna","year":"2018","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.ejphar.2025.178090_bib50","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1111\/bcp.15780","article-title":"Spotlight commentary: the value of spontaneous reporting systems to detect (the lack of) clinically relevant drug-drug interactions in clinical practice","volume":"89","author":"Raschi","year":"2023","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178090_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2024.102343","article-title":"A systematic review of the potential treatment effects of topical epidermal growth factor for ocular surface disorders","volume":"48","author":"Sanie-Jahromi","year":"2025","journal-title":"Contact Lens Anterior Eye"},{"key":"10.1016\/j.ejphar.2025.178090_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1378090","article-title":"CDK4\/6 inhibitors in drug-induced liver injury: a pharmacovigilance study of the FAERS database and analysis of the drug-gene interaction network","volume":"15","author":"She","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178090_bib53","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.17219\/acem\/50572","article-title":"Mycotic infections of the eye","volume":"24","author":"S\u0142owik","year":"2015","journal-title":"Adv. Clin. Exp. Med."},{"key":"10.1016\/j.ejphar.2025.178090_bib54","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000371712","article-title":"Cytotoxic effect of voriconazole on human corneal epithelial cells","volume":"54","author":"Sobolewska","year":"2015","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.ejphar.2025.178090_bib55","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/psp4.12765","article-title":"Advancing drug safety science by integrating molecular knowledge with post-marketing adverse event reports","volume":"11","author":"Soldatos","year":"2022","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178090_bib56","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12348-020-00230-2","article-title":"Drug-induced ectropion following the chronic use of topical natamycin","volume":"10","author":"Soleimani","year":"2020","journal-title":"J. Ophthalmic Inflamm Infect."},{"key":"10.1016\/j.ejphar.2025.178090_bib57","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1136\/bjo.2006.103028","article-title":"Corneal ulceration in south-east Asia III: prevention of fungal keratitis at the village level in South India using topical antibiotics","volume":"90","author":"Srinivasan","year":"2006","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ejphar.2025.178090_bib58","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1001\/archophthalmol.2011.364","article-title":"Dry eye disease: an immune-mediated ocular surface disorder","volume":"130","author":"Stevenson","year":"2012","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.ejphar.2025.178090_bib59","article-title":"Fungal panophthalmitis presenting as severe posterior scleritis","volume":"32","author":"Sun","year":"2023","journal-title":"Am J. Ophthalmol. Case Rep."},{"key":"10.1016\/j.ejphar.2025.178090_bib60","first-page":"181","article-title":"Threats to validity in retrospective studies","volume":"3","author":"Tofthagen","year":"2012","journal-title":"J. Adv. Pract Oncol."},{"key":"10.1016\/j.ejphar.2025.178090_bib61","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/pds.5624","article-title":"Sensitivity and specificity in signal detection with the reporting odds ratio and the information component","volume":"32","author":"Trillenberg","year":"2023","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.ejphar.2025.178090_bib62","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2147\/OPTH.S10819","article-title":"Fungal keratitis","volume":"5","author":"Tuli","year":"2011","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.ejphar.2025.178090_bib63","doi-asserted-by":"crossref","first-page":"237","DOI":"10.4103\/0301-4738.27947","article-title":"Retinal toxicity of intravitreally injected plain and liposome formulation of fluconazole in rabbit eye","volume":"54","author":"Velpandian","year":"2006","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.ejphar.2025.178090_bib64","first-page":"1","article-title":"Pharmacovigilance study and genetic target prediction analysis of FDA adverse event reports (FAERS) for drug-induced sinusitis","author":"Wang","year":"2025","journal-title":"Expet Opin. Drug Saf."},{"key":"10.1016\/j.ejphar.2025.178090_bib65","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/APO.0000000000000571","article-title":"Diabetic patients with rosacea increase the risks of diabetic macular edema, dry eye disease, glaucoma, and cataract","volume":"11","author":"Wang","year":"2022","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"10.1016\/j.ejphar.2025.178090_bib66","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/andr.13533","article-title":"A real-world pharmacovigilance study of FDA adverse event reporting system events for sildenafil","volume":"12","author":"Wang","year":"2024","journal-title":"Andrology"},{"key":"10.1016\/j.ejphar.2025.178090_bib67","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s11552-011-9321-0","article-title":"Erratum to: why I hate the index finger","volume":"6","author":"White","year":"2011","journal-title":"Hand"},{"key":"10.1016\/j.ejphar.2025.178090_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2025.199561","article-title":"Regulation of inflammatory cytokines and activation of PI3K\/Akt pathway by yiqi jiedu formula in recurrent Herpes simplex keratitis: experimental and network pharmacology evidence","volume":"355","author":"Xiao","year":"2025","journal-title":"Virus Res."},{"key":"10.1016\/j.ejphar.2025.178090_bib69","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1167\/iovs.14-15270","article-title":"Voriconazole, an antifungal triazol that causes visual side effects, is an inhibitor of TRPM1 and TRPM3 channels","volume":"56","author":"Xiong","year":"2015","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejphar.2025.178090_bib70","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/17425255.2023.2219390","article-title":"A real-world data analysis of topotecan in the FDA adverse event reporting system (FAERS) database","volume":"19","author":"Yang","year":"2023","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.ejphar.2025.178090_bib71","doi-asserted-by":"crossref","first-page":"7475","DOI":"10.2147\/IDR.S391022","article-title":"Central nervous system toxicity of voriconazole: risk factors and threshold - a retrospective cohort study","volume":"15","author":"Yang","year":"2022","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.ejphar.2025.178090_bib72","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1442-9071.2008.01795.x","article-title":"Bilateral anterior optic neuropathy associated with use of terbinafine","volume":"36","author":"Y\u00fclek","year":"2008","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.ejphar.2025.178090_bib73","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1080\/14740338.2024.2391492","article-title":"Voriconazole-induced central nervous system toxicity: a pharmacovigilance study based on FDA adverse event reporting system (FAERS) database","volume":"23","author":"Yun","year":"2024","journal-title":"Expet Opin. Drug Saf."},{"key":"10.1016\/j.ejphar.2025.178090_bib74","doi-asserted-by":"crossref","first-page":"10072","DOI":"10.1007\/s12035-024-04245-x","article-title":"Isavuconazole induces neurodevelopment defects and motor behaviour impairment in zebrafish larvae","volume":"61","author":"Zhang","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2025.178090_bib75","article-title":"A real-world disproportionality analysis of everolimus: data mining of the public version of FDA adverse event reporting system","volume":"15","author":"Zhao","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178090_bib76","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/17425255.2023.2235267","article-title":"A real-world data analysis of acetylsalicylic acid in FDA adverse event reporting system (FAERS) database","volume":"19","author":"Zhao","year":"2023","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.ejphar.2025.178090_bib77","first-page":"1","article-title":"Comprehensive post-marketing safety analysis of tildrakizumab: insights from the FDA adverse event reporting system","author":"Zhao","year":"2025","journal-title":"Expet Opin. Drug Saf."},{"key":"10.1016\/j.ejphar.2025.178090_bib78","doi-asserted-by":"crossref","DOI":"10.1007\/s11096-025-01896-1","article-title":"Real-world safety of deucravacitinib: insights from the food and drug administration adverse event reporting system","author":"Zhao","year":"2025","journal-title":"Int. J. Clin. Pharm."},{"key":"10.1016\/j.ejphar.2025.178090_bib79","article-title":"Assessing the real-world safety of tralokinumab for atopic dermatitis: insights from a comprehensive analysis of FAERS data","volume":"15","author":"Zhao","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178090_bib80","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1080\/14740338.2024.2410436","article-title":"A real-world pharmacovigilance study using disproportionality analysis of United States food and drug administration adverse event reporting system events for vinca alkaloids: comparing vinorelbine and vincristine","volume":"23","author":"Zhong","year":"2024","journal-title":"Expet Opin. Drug Saf."},{"key":"10.1016\/j.ejphar.2025.178090_bib81","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/ng.3538","article-title":"Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets","volume":"48","author":"Zhu","year":"2016","journal-title":"Nat. Genet."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925008441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925008441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T16:22:08Z","timestamp":1772814128000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925008441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":81,"alternative-id":["S0014299925008441"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178090","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ocular safety evaluation of toplic and systemic antifungal medications: A multi-source pharmacovigilance and genomic study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178090","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"178090"}}